Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Harmony Biosciences | HRMY | Nov 27, 2024 | 35.75 | +2.64 |
Harmony Gold Mining ADR | HMY | Nov 27, 2024 | 9.07 | -2.05 |
Harrow | HROW | Nov 27, 2024 | 42.47 | +0.54 |
Hartford Financial Services G Pref | HIG-G | Nov 27, 2024 | 25.06 | -0.08 |
Hartford Financial Services Group | HIG | Nov 27, 2024 | 123.74 | +0.91 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | Nov 27, 2024 | 29.59 | +0.48 |
Harvard Bioscience | HBIO | Nov 27, 2024 | 2.20 | +0.46 |
Hasbro | HAS | Nov 27, 2024 | 63.89 | -0.17 |
Haverty Furniture Companies | HVT-A | Nov 27, 2024 | 24.41 | 0.00 |
Haverty Furniture Companies | HVT | Nov 27, 2024 | 24.06 | +0.97 |
Hawaiian Electric Industries | HE | Nov 27, 2024 | 10.53 | -0.38 |
Hawkins | HWKN | Nov 27, 2024 | 133.39 | -2.85 |
Hawthorn Bancshares | HWBK | Nov 27, 2024 | 32.75 | +3.84 |
Haymaker Acquisition 4 | HYAC | Nov 27, 2024 | 10.75 | +0.18 |
Haynes International | HAYN | Nov 27, 2024 | 60.99 | 0.00 |
Hayward | HAYW | Nov 27, 2024 | 16.18 | -0.92 |
HBT Financial | HBT | Nov 27, 2024 | 23.94 | -0.75 |
HCA Healthcare | HCA | Nov 27, 2024 | 325.47 | -1.06 |
HCI Group | HCI | Nov 27, 2024 | 116.71 | +0.60 |
HCM II Acquisition | HONDU | Nov 27, 2024 | 10.06 | 0.00 |
HCM II Acquisition | HOND | Nov 27, 2024 | 10.01 | 0.00 |
HCW Biologics | HCWB | Nov 27, 2024 | 0.50 | -10.08 |
HDFC Bank ADR | HDB | Nov 27, 2024 | 67.50 | +1.28 |
Health Catalyst | HCAT | Nov 27, 2024 | 8.65 | +1.76 |
Healthcare AI Acquisition A | HAIA | Nov 27, 2024 | 11.43 | 0.00 |
Healthcare Alphadex First Trust | FXH | Nov 27, 2024 | 111.37 | +0.17 |
Healthcare Bull 3X Direxion | CURE | Nov 27, 2024 | 112.60 | +1.49 |
Healthcare ETF Vanguard | VHT | Nov 27, 2024 | 271.38 | +0.54 |
Healthcare Realty Trust | HR | Nov 27, 2024 | 18.48 | -0.38 |
Healthcare Select Sector SPDR | XLV | Nov 27, 2024 | 146.95 | +0.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.